Last reviewed · How we verify
NCT05465811
Telerehabilitation on Physical and Mental Health of the Elderly in the Covid-19 Pandemic Context
NA trial testing Program of physical exercises and health education by telerehabilitation in Elderly Women in 8 participants. Completed in 16 August 2022.
16 August 2022
Quick facts
| Lead sponsor | Paulista University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 8 |
| Start date | 10 January 2022 |
| Primary completion | 16 August 2022 |
| Estimated completion | 16 August 2022 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Program of physical exercises and health education by telerehabilitation
Conditions studied
- Elderly Women — all drugs for Elderly Women →
Sponsor
Paulista University
Who can join
60 and older, female only, with Elderly Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Due to the COVID-19 pandemic scenario, social distancing has become the main strategy to contain this pandemic, causing negative impacts on the physical and mental health of the elderly population. To promote the continuity of offering health services during isolation telerehabilitation was used. Thus, it is important to investigate the effect of a physical exercise program and health education through telerehabilitation on physical and mental aspects in order to establish it as an alternative care for the elderly. Objectives: To evaluate the effect of a program of physical exercises and health education by telerehabilitation on signs of sarcopenia, physical performance, hand grip strength and levels of anxiety, depression and sleep quality in elderly women. Method: In this non-randomized clinical trial, considered a pilot study, eight elderly women (73,00±4,69 years old) will be submitted to 16 weeks of intervention through a program of physical exercise and health education using the Google Meet platform (synchronous online), frequency of 3 weekly sessions and duration of 50' (Initial rest: 5'; Warm-up: 15': Resistance exercises: 20'; Stretching exercises: 5'; Relaxation and final rest: 5'). Before and after the intervention period, the following tests will be applied: SARC-F, Short Physical Performance Battery, hand-grip dynamometry, Geriatric Anxiety Inventory, Geriatric Depression Scale and Pittsburgh Sleep Quality Index. To compare the two moments, the paired Student's T-test or Wilcoxon test (normality assessed by the Shapiro-Wilk test) will be used with p\<0.05.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05465811
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Paulista University trials
Trials by the same sponsor.
- NCT06512961 — Applicability of Tissue Flossing for Blood Flow Restriction in the Upper Limb: Reliability and Performance Analysis · NA · enrolling by invitation
- NCT05523674 — Effects of Warm-up Intensity and Blood Flow Restriction · NA · completed
- NCT05059652 — Effects of Ischemic Preconditioning on Conditioned Pain Modulation and Heart Rate Variability in Knee Osteoarthritis · NA · completed
- NCT04420819 — Effects of Ischemic Preconditioning on Muscle Damage Induced by Excentric Exercise · NA · completed
- NCT03601104 — Effects of Low Intensity, High Intensity Eccentric Resistance Training Associated With Blood Flow Restriction · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05465811 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Paulista University
- Last refreshed: 17 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05465811.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing